Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

  • Exchange: Hong Kong
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Lee's Pharmaceutical Holdings Ltd

+ Add to Watchlist

950:HK

11.700 HKD 0.100 0.86%

As of 03:01:04 ET on 01/30/2015.

Snapshot for Lee's Pharmaceutical Holdings Ltd (950)

Open: 11.600 Day's Range: 11.500 - 12.180 Volume: 277,298
Previous Close: 11.600 52wk Range: 7.100 - 13.200 1-Yr Rtn: +61.46%

Stock Chart for 950

No chart data available.
  • 950:HK 11.700
  • 1D
  • 1M
  • 1Y
11.600
Interactive 950 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 950

Current P/E Ratio (ttm) 36.1211
Estimated P/E(12/2014) 33.9130
Relative P/E vs. HSI 3.4573
Earnings Per Share (HKD) (ttm) 0.3239
Est. EPS (HKD) (12/2014) 0.3450
Est. PEG Ratio -
Market Cap (M HKD) 6,453.89
Shares Outstanding (M) 551.61
30 Day Average Volume 139,475
Price/Book (mrq) -
Price/Sale (ttm) 7.2489
Dividend Indicated Gross Yield 0.68%
Cash Dividend (HKD) 0.0270
Dividend Ex-Date 09/15/2014
5 Year Dividend Growth 32.98%
Next Earnings Announcement 03/20/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 950

  • Revenue
  • Net Income (M/HKD)
  • Profit Margin (%)

Company Profile & Key Executives for 950

Lee's Pharmaceutical Holdings Limited develops, manufactures and sells quality biopharmaceutical products that focus on combating cardiovascular diseases and viral sexually transmitted diseases.

Lee Siu FongChairmanLi XiaoyiCEO/CTO/Founder
Chow Yiu MingCFO/SecretaryLeelalertsuphakun WaneeChief Mktg & Sales Officer
More Company Profile & Key Executives for 950

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil